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Bacteria SAVED from viruses 
 
Abstract 
Increasingly, cyclic nucleotide second messengers are implicated in antiviral defence systems 
in bacteria and archaea as well as eukaryotes. Lowey et al. describe SAVED - a widespread, 
uncharacterised cyclic nucleotide sensor protein domain that activates cell defence systems. 
The structure of SAVED reveals links to the CRISPR system, which also generates cyclic 
nucleotides in response to viral infection. 
 
Just like humans, microbes are frequently infected by viruses. Consequently, a wide range of 
defence systems, including restriction-modification and CRISPR, are employed to prevent 
infection spreading in a microbial population. Cyclic nucleotide second messengers are 
increasingly implicated in a wide range of antiviral defence systems in bacteria and archaea. 
These are collectively known as CBASS (“cyclic-oligonucleotide-based antiphage signalling 
systems”) (Cohen et al., 2019), in a nod towards the eukaryotic cGAS antiviral signalling 
system. The diversity of CBASS is remarkable, arising from a wide range of cGAS/DncV-like 
Nucleotidyltransferases (CD-NTases) that synthesise a diverse collection of cyclic nucleotide 
second messengers, in turn activating a variety of effector proteins to effect immunity. Most 
of these systems remain uncharacterised, but Kranzusch and colleagues take a significant step 
forward in this issue by elucidating the structure and function of the enigmatic SAVED 
(Burroughs et al., 2015), found in many CBASS (Lowey, 2020). SAVED stands for “SMODS-
associated and fused to various effector domains” – seldom was an acronym more welcome. 
 
The authors focussed on a CBASS from the bacterium Enterobacter cloacae, comprising the 
CD-NTase CdnD and three associated genes (cap2, cap3 and cap4). Previously, it was 
demonstrated that CdnD synthesises the cyclic trinucleotide second messenger 3’,3’,3’-cAAG 
(Whiteley et al., 2019). Here they show that the second messenger binds to the C-terminal 
SAVED domain of Cap4. This potentiates a structural rearrangement, resulting in activation of 
a potent N-terminal endonuclease that degrades DNA. The system provides immunity against 
infection by T2 and T5 (but intriguingly not T7) bacteriophage in vivo. 
 
The structure of Cap4 in complex with a cyclic trinucleotide reveals that SAVED domains are 
distant family members of the CARF (CRISPR associated Rossmann fold) domain superfamily, 
confirming recent predictions (Shmakov et al., 2018). CARF proteins act as sensors for the 
cyclic oligoadenylate second messengers generated by the Cas10 cyclase domain of type III 
CRISPR systems (Kazlauskiene et al., 2017), and like SAVED domains are normally fused to 
effector proteins such as nucleases (Koonin and Makarova, 2018). While CARF domains are 
dimeric and bind oligoadenylate ligands with 2-fold symmetry, the monomeric SAVED domain 
is capable of recognising a diverse range of asymmetric ligands with different nucleobases 
and phospho-diester linkages. Moreover, SAVED domains are fused to a wide variety of 
effector domains, including nucleases, phospholipases, proteases and pore-forming proteins. 
In some bacteria, SAVED domain proteins are found in association with type III CRISPR 
systems, suggesting their ligand is the cyclic-triadenylate (cA3) product of the Cas10 cyclase. 
This is also the ligand for the evolutionarily unrelated endonuclease NucC, a CBASS effector 
that binds cA3 directly, resulting in hexamerization and nuclease activation (Lau et al., 2020). 
The diversity of cyclic nucleotide second messengers and effectors utilized by CBASS and 
CRISPR systems may have evolved as a response to pressure from viruses, which frequently 
encode proteins that degrade second messengers and inhibit effector enzymes to suppress 
cellular immunity. 
 
Elucidation of the structure and function of SAVED represents a significant advance in our 
understanding of CBASS. However, a number of important questions remain. Firstly, the 
mechanism of activation of CD-NTases is not understood. These enzymes tend to be 
constitutively active in vitro, and CBASS can be transplanted between different bacteria to 
provide effective anti-phage defence, but we don’t yet know how the system is activated. 
Simple detection of viral DNA is unlikely to be straightforward for prokaryotes that cannot 
compartmentalise their genomes. Secondly, it is striking that many CBASS encode ubiquitin-
like conjugation and protease machinery – in this case represented by the cap2 and cap3 
genes of the operon. So far, there is no clue as to the function of this aspect of CBASS, but we 
can expect rapid progress and further surprises. Finally, by activating a broad specificity 
endonuclease for defence, cells with a Cap4 effector may, rather than being “saved”, be 
signing their own death warrant. Most CBASS likely function using an Abortive Infection (Abi) 
model, committing altruistic suicide to prevent completion of the bacteriophage replication 
cycle (Cohen et al., 2019).  Although perhaps counter-intuitive for a unicellular organism, this 
approach can be favoured by evolution if neighbours sharing genetic material are spared viral 
infection (Hampton et al., 2020). 
 
To conclude, the discovery that SAVED and CARF domains are evolutionarily related and share 
common functions in the detection of cyclic nucleotides, leading to activation of fused 
effector proteins for anti-viral defence, represents a signficant advance in our understanding 
of these complex systems. 
 
Figure 1. CBASS and CRISPR pathways for anti-phage defence. Phage infection activates 
CBASS pathways by an unknown mechanism. The nucleotide cyclase CdnD generates a cyclic-
AAG second messenger that binds to the SAVED domain of Cap4, activating the N-terminal 
DNA nuclease domain. Alternative CBASS systems generate different second messengers and 
activate diverse effectors such as the NucC endonuclease (Lau et al., 2020) that are thought 
to kill cells, preventing phage replication. CBASS systems are frequently found in association 
with Ubiquitin-like modification machinery (JAMM, E1 and E2) of unknown function. Type III 
CRISPR systems detect viral RNA and synthesise cyclic oligoadenylates, activating defence 
enzymes such as NucC and the extensive CARF family of effector proteins. CARF and SAVED 
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